Clinical Trial Update: Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Vytorin (ezetimibe/simvastatin) for newly diagnosed dyslipidemia has completed with results posted in August 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2010-08-26